Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Inflammatory Bowel Diseases

Free Subscription Articles published in J Clin Gastroenterol Retrieve available abstracts of 80 articles: HTML format

Single Articles

April 2024
1. KARIME C, Salazar M, Black CN, Caldera F, et al
   In Patients With Inflammatory Bowel Disease, Racial Disparities Exist in Burden of Vaccine-preventable Disease Hospitalizations and Outcomes.
   J Clin Gastroenterol. 2024 Apr 16. doi: 10.1097/MCG.0000000000002005.
   PubMed     Abstract available
   
   
   
2. PETROV JC, Al-Bawardy B, Alzahrani R, Mohamed G, et al
   Rates, Predictors, and Outcomes of Ustekinumab Dose Escalation in Inflammatory Bowel Disease.
   J Clin Gastroenterol. 2024 Apr 10. doi: 10.1097/MCG.0000000000002003.
   PubMed     Abstract available
   
   
   March 2024
3. DOLOVICH C, Shafer LA, Graff LA, Vagianos K, et al
   Hormonal Contraceptives Reduce Active Symptomatic Disease but May Increase Intestinal Inflammation in IBD.
   J Clin Gastroenterol. 2024;58:271-276.
   PubMed     Abstract available
   
   
   
4. KHAN N, Trivedi C, Shah Y, Patel M, et al
   Incidence of Pneumonia, Related Hospitalization, and Mortality Among Younger Unvaccinated IBD Patients in a Nationwide Cohort.
   J Clin Gastroenterol. 2024;58:277-280.
   PubMed     Abstract available
   
   
   February 2024
5. GODOY-BREWER G, Salem G, Limketkai B, Selaru FM, et al
   Use of Biologics for the Treatment of Inflammatory Conditions of the Pouch: A Systematic Review.
   J Clin Gastroenterol. 2024;58:183-194.
   PubMed     Abstract available
   
   
   
6. PETROV J, Fine S, Alzahrani R, Mohamed G, et al
   Ustekinumab Drug Levels and Outcomes in Inflammatory Bowel Disease.
   J Clin Gastroenterol. 2024 Feb 1. doi: 10.1097/MCG.0000000000001978.
   PubMed     Abstract available
   
   
   January 2024
7. VARMA A, Weinstein J, Seabury J, Rosero S, et al
   The Crohn's Disease-Health Index: Development and Evaluation of a Novel Outcome Measure.
   J Clin Gastroenterol. 2024 Jan 26. doi: 10.1097/MCG.0000000000001976.
   PubMed     Abstract available
   
   
   December 2023
8. KARIME C, Crosby S, Bhat S, Hashash JG, et al
   Rapid Adoption of Pneumococcal 20-Valent Conjugate Vaccination in Adult Patients With Inflammatory Bowel Disease: An Analysis One Year After Availability.
   J Clin Gastroenterol. 2023 Dec 5. doi: 10.1097/MCG.0000000000001954.
   PubMed    
   
   
   November 2023
9. BACHOUR SP, Shah RS, Joseph A, Syed H, et al
   Change in Biologic Class Promotes Endoscopic Remission Following Endoscopic Postoperative Crohn's Disease Recurrence.
   J Clin Gastroenterol. 2023 Nov 27. doi: 10.1097/MCG.0000000000001943.
   PubMed     Abstract available
   
   
   October 2023
10. NARULA N, Wong ECL, Aruljothy A, Dulai PS, et al
    Baseline Patient-reported Symptoms Less Predictive Than MM-SES-CD for Endoscopic Remission in Crohn's Disease.
    J Clin Gastroenterol. 2023;57:913-919.
    PubMed     Abstract available
    
    
    September 2023
11. DOKMAK A, Sweigart B, Orekondy NS, Jangi S, et al
    Efficacy and Safety of Hyperbaric Oxygen Therapy in Fistulizing Crohn's Disease: A Systematic Review and Meta-analysis.
    J Clin Gastroenterol. 2023 Sep 11. doi: 10.1097/MCG.0000000000001905.
    PubMed     Abstract available
    
    
    August 2023
12. SMITH ES, Chen J, Pan Y, Mahtani P, et al
    The Relationship Between the Endoscopic Healing Index, Fecal Calprotectin, and Magnetic Resonance Enterography in Crohn's Disease.
    J Clin Gastroenterol. 2023 Aug 21. doi: 10.1097/MCG.0000000000001904.
    PubMed     Abstract available
    
    
    
13. DA CUNHA T, Vaziri H
    Interval Colorectal Cancer in Inflammatory Bowel Disease: A Review.
    J Clin Gastroenterol. 2023 Aug 7. doi: 10.1097/MCG.0000000000001901.
    PubMed     Abstract available
    
    
    July 2023
14. BERNSTEIN CN, Dolovich C, Prichodko M, Fisk JD, et al
    Perceived Need for Mental Health Care in a Cohort of Persons With Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2023 Jul 21. doi: 10.1097/MCG.0000000000001892.
    PubMed     Abstract available
    
    
    
15. GUBATAN J, Frost S, Levitte S, Keyashian K, et al
    Rates and Predictors of Long-term Clinical Outcomes in Patients With Perianal Crohn's Disease on Biologic Therapy.
    J Clin Gastroenterol. 2023;57:617-623.
    PubMed     Abstract available
    
    
    June 2023
16. DESAI A, Hashash JG, Baker G, Farraye FA, et al
    Effect of Bariatric Surgery on Disease Outcomes in Patients with Inflammatory Bowel Disease: A US-based Propensity Matched Cohort Study.
    J Clin Gastroenterol. 2023 Jun 27. doi: 10.1097/MCG.0000000000001879.
    PubMed     Abstract available
    
    
    
17. KARIME C, Hashash JG, Picco MF, Craver EC, et al
    The Effect of Renin-Angiotensin-Aldosterone System Blocking Agents on the Long-term Disease Course of Patients With Crohn's Disease.
    J Clin Gastroenterol. 2023 Jun 26. doi: 10.1097/MCG.0000000000001881.
    PubMed     Abstract available
    
    
    May 2023
18. BERNSTEIN CN, Regueiro M
    Postoperative Crohn's Disease.
    J Clin Gastroenterol. 2023 May 24. doi: 10.1097/MCG.0000000000001865.
    PubMed     Abstract available
    
    
    
19. DAHIYA DS, Chandan S, Bapaye J, Mohan BP, et al
    Safety and Effectiveness of Vedolizumab in Elderly Patients with Inflammatory Bowel Disease: A Systematic Review & Meta-Analysis.
    J Clin Gastroenterol. 2023 May 23. doi: 10.1097/MCG.0000000000001860.
    PubMed     Abstract available
    
    
    February 2023
20. ZEINA T, Gandhi S, Mittal A, Levy AN, et al
    Predictors and Etiologies of Clinical Relapse Among Patients With Ulcerative Colitis in Deep Remission.
    J Clin Gastroenterol. 2023 Feb 8. doi: 10.1097/MCG.0000000000001834.
    PubMed     Abstract available
    
    
    
21. WEISSMAN S, Systrom HK, Bangolo A, Elias D, et al
    Health Maintenance and Preventative Care in Inflammatory Bowel Disease: A Systematic Review of the Overall Quality of Societal Recommendations.
    J Clin Gastroenterol. 2023 Feb 3. doi: 10.1097/MCG.0000000000001833.
    PubMed     Abstract available
    
    
    January 2023
22. DASHARATHY SS, May FP, Myint A, Yang L, et al
    Pneumococcal Vaccination Recommendation and Completion Rates Among Patients With Inflammatory Bowel Disease and Barriers to Vaccination.
    J Clin Gastroenterol. 2023 Jan 19. doi: 10.1097/MCG.0000000000001783.
    PubMed     Abstract available
    
    
    
23. TIWARI A, Ashraf A, Bharali P
    Tofacitinib in Ulcerative Colitis-evolving Efficacy and Safety.
    J Clin Gastroenterol. 2023 Jan 3. doi: 10.1097/MCG.0000000000001823.
    PubMed    
    
    
    
24. BHATTACHARYA A, Travis D, Osterman MT, Lewis JD, et al
    Supratherapeutic Infliximab Levels Do Not Predict Risk of Short-term Complications in Adults With Crohn's Disease.
    J Clin Gastroenterol. 2023;57:66-73.
    PubMed     Abstract available
    
    
    
25. THOMANN AK, Knodler LL, Karthikeyan S, Atanasova K, et al
    The Interplay of Biopsychosocial Factors and Quality of Life in Inflammatory Bowel Diseases: A Network Analysis.
    J Clin Gastroenterol. 2023;57:57-65.
    PubMed     Abstract available
    
    
    December 2022
26. JOHNSON AM, Harmsen WS, Aniwan S, Tremaine WJ, et al
    Prevalence and Impact of Obesity in a Population-Based Cohort of Patients With Crohn's Disease.
    J Clin Gastroenterol. 2022 Dec 30. doi: 10.1097/MCG.0000000000001821.
    PubMed     Abstract available
    
    
    November 2022
27. BALESTRIERI P, Ribolsi M, Cimini P, Alvaro G, et al
    Wall Thickness Ratio-A New Magnetic Resonance Parameter-Is Associated With the Outcome of Biological Therapy in Patients With Ileal and Ileocolonic Crohn's Disease.
    J Clin Gastroenterol. 2022 Nov 21. doi: 10.1097/MCG.0000000000001809.
    PubMed     Abstract available
    
    
    
28. KILINCALP S, Yuksel I
    The Influence of Coexisting Familial Mediterranean Fever on Crohn's Disease: Data From an FMF Endemic Area.
    J Clin Gastroenterol. 2022 Nov 15. doi: 10.1097/MCG.0000000000001798.
    PubMed     Abstract available
    
    
    
29. GUERRERO VINSARD D, Wakefield D, Karagozian R, Farraye FA, et al
    Herpes Zoster in Hospitalized Patients With Inflammatory Bowel Disease: National Analysis of Disease Presentation and Age Distribution.
    J Clin Gastroenterol. 2022 Nov 9. pii: 00004836-990000000-00090.
    PubMed     Abstract available
    
    
    
30. GUTIERREZ-VALENCIA M, Leache L, Saiz LC, Beloqui JJ, et al
    Role of Pharmacogenomics in the Efficacy and Safety of Thiopurines in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    J Clin Gastroenterol. 2022 Nov 3. pii: 00004836-990000000-00089.
    PubMed     Abstract available
    
    
    October 2022
31. GREYWOODE R, Cunningham C, Hollins M, Aroniadis O, et al
    Medical Cannabis Use Patterns and Adverse Effects in Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2022 Oct 14. pii: 00004836-990000000-00077.
    PubMed     Abstract available
    
    
    September 2022
32. WANG CP, Zylberberg HM, Borman ZA, Engelman S, et al
    Impact of Care in an Interdisciplinary Inflammatory Bowel Disease Specialty Clinic on Outcomes in Patients Insured with Medicaid.
    J Clin Gastroenterol. 2022 Sep 23. pii: 00004836-990000000-00066.
    PubMed     Abstract available
    
    
    
33. RISKIN GEUZ KS, Schwartz D
    Less Emergency Department Abdominopelvic Computed Tomography for Patients With Crohn's Disease: A New Scoring System.
    J Clin Gastroenterol. 2022;56:712-717.
    PubMed     Abstract available
    
    
    August 2022
34. FUSS A, Lease S
    Moderating the Relationship Between Ulcerative Colitis and Crohn's Disease and Symptoms of PTSD: The Role of Remission.
    J Clin Gastroenterol. 2022 Aug 22. pii: 00004836-990000000-00051.
    PubMed     Abstract available
    
    
    
35. AKIYAMA S, Hamdeh S, Sakamoto T, Suzuki H, et al
    The Feasibility, Safety, and Long-term Outcomes of Endoscopic Submucosal Dissection for Colorectal Neoplasia in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    J Clin Gastroenterol. 2022 Aug 9. pii: 00004836-990000000-00042.
    PubMed     Abstract available
    
    
    
36. DALAL RS, Mitri J, Goodrick H, Allegretti JR, et al
    Risk of Gastrointestinal Infections After Initiating Vedolizumab and Anti-TNFalpha Agents for Ulcerative Colitis.
    J Clin Gastroenterol. 2022 Aug 4. pii: 00004836-990000000-00040.
    PubMed     Abstract available
    
    
    July 2022
37. REDDY S, Shore B, Abramson L, Herfarth HH, et al
    Same Day Infusion of Iron Therapy Is Associated With No Increased Risk for Adverse Events Among Patients Receiving Biological Infusions for Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2022 Jul 22. pii: 00004836-990000000-00036.
    PubMed     Abstract available
    
    
    June 2022
38. TRIVEDI HD, Lopes EW, Glissen Brown J, Dudani S, et al
    Steroid Use and Risk of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-analysis.
    J Clin Gastroenterol. 2022 Jun 1. pii: 00004836-990000000-00030.
    PubMed     Abstract available
    
    
    April 2022
39. KIM ES, Kim SK, Park DI, Kim HJ, et al
    Comparison of the Pharmacokinetics of CT-P13 Between Crohn's Disease and Ulcerative Colitis.
    J Clin Gastroenterol. 2022 Apr 26. pii: 00004836-990000000-00020.
    PubMed     Abstract available
    
    
    
40. AGGARWAL M, Alkhayyat M, Abou Saleh M, Sarmini MT, et al
    Alzheimer Disease Occurs More Frequently In Patients With Inflammatory Bowel Disease: Insight From a Nationwide Study.
    J Clin Gastroenterol. 2022 Apr 21. pii: 00004836-990000000-00017.
    PubMed     Abstract available
    
    
    
41. GIRI S, Darak H
    Increased Risk of Infection With High Infliximab Trough Level: West Versus East.
    J Clin Gastroenterol. 2022;56:374.
    PubMed    
    
    
    March 2022
42. BATTAT R, Galati JS, Lukin D, Chabouni F, et al
    A Quality Improvement Initiative Is Associated With Reduced Time to Administer Biologics and Small Molecules and Emergency Room Visits in Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2022;56:e176-e182.
    PubMed     Abstract available
    
    
    
43. BATTAT R, Qatomah A, Kopylov U, Wyse J, et al
    Fucosyltransferase 2 Mutations Are Associated With a Favorable Clinical Course in Crohn's Disease.
    J Clin Gastroenterol. 2022;56:e166-e170.
    PubMed     Abstract available
    
    
    
44. OLLECH JE, Waizbard A, Lubetsky A, Kopylov U, et al
    Venous Thromboembolism Among Patients With Inflammatory Bowel Diseases is Not Related to Increased Thrombophilia: A Case-Control Study.
    J Clin Gastroenterol. 2022;56:e222-e226.
    PubMed     Abstract available
    
    
    
45. GOREN I, Sharvit G, Godny L, Fatal SE, et al
    Exploring Popular Social Media Networks for Patients With Inflammatory Bowel Diseases: Insights for Better Care.
    J Clin Gastroenterol. 2022;56:e203-e208.
    PubMed     Abstract available
    
    
    February 2022
46. WANG H, Fewings I, Bornman L, Shadbolt B, et al
    Histologic Remission (NANCY Index) is Superior to Endoscopic Mucosal Healing in Predicting Relapse Free Survival in Patients With Ulcerative Colitis in Clinical and Endoscopic Remission.
    J Clin Gastroenterol. 2022 Feb 28. pii: 00004836-900000000-97305.
    PubMed     Abstract available
    
    
    
47. TANEJA V, Stein DJ, Feuerstein JD
    Impact of Cirrhosis on Outcomes in Inflammatory Bowel Disease Hospitalizations.
    J Clin Gastroenterol. 2022 Feb 14. pii: 00004836-900000000-97315.
    PubMed     Abstract available
    
    
    
48. KRONER PT, Picco MF, Cangemi JR, Hayney MS, et al
    The Burden of Vaccine-preventable Diseases in Patients With Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2022 Feb 14. pii: 00004836-900000000-97313.
    PubMed     Abstract available
    
    
    
49. GOREN I, Barkan R, Biron IA, Leibovitzh H, et al
    Specialized Emergency Department Assessment and Multidisciplinary Intervention After Discharge Improve Management of Patients With Inflammatory Bowel Diseases.
    J Clin Gastroenterol. 2022;56:148-153.
    PubMed     Abstract available
    
    
    January 2022
50. TANDON P, O'Connor K, Nguyen G, Maxwell C, et al
    The COVID-19 Pandemic Significantly Impacts Pregnancy Planning and Mental Health of Women With Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2022 Jan 26. pii: 00004836-900000000-97320.
    PubMed     Abstract available
    
    
    
51. VARMA S, Green PH, Krishnareddy S
    Clinical Factors Associated With Positive Stool PCR for Gastrointestinal Pathogens in Celiac and Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2022 Jan 10. pii: 00004836-900000000-97329.
    PubMed     Abstract available
    
    
    
52. VARMA S, Green PH, Krishnareddy S
    The Distribution of Gastrointestinal Pathogens on Stool PCR Prior to the Development of IBD.
    J Clin Gastroenterol. 2022;56:e52-e57.
    PubMed     Abstract available
    
    
    
53. AWADIE H, Waterman M
    Intermittent Appearance of Antibodies to Infliximab Is Not Associated With Reduced Efficacy in Patients With Inflammatory Bowel Diseases.
    J Clin Gastroenterol. 2022;56:e47-e51.
    PubMed     Abstract available
    
    
    
54. VAN WASSENAER EA, Diederen K, van Leeuwen EMM, D'Haens GR, et al
    Can 2 Different Fecal Calprotectin Assays be Used Interchangeably in IBD Treatment?
    J Clin Gastroenterol. 2022;56:e27-e30.
    PubMed     Abstract available
    
    
    December 2021
55. HART LC, Arvanitis M, Sawicki GS, Diaz-Gonzalez de Ferris M, et al
    Trajectories of the Transition Readiness Assessment Questionnaire Among Youth With Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2021 Dec 15. pii: 00004836-900000000-97345.
    PubMed     Abstract available
    
    
    
56. MESONERO F, Fernandez C, Sanchez-Rodriguez E, Garcia-Garcia Paredes A, et al
    Polypharmacy in Patients With Inflammatory Bowel Disease: Prevalence and Outcomes in a Single-center Series.
    J Clin Gastroenterol. 2021 Dec 6. pii: 00004836-900000000-97347.
    PubMed     Abstract available
    
    
    
57. TARIQ R, Syed T, Yadav D, Prokop LJ, et al
    Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    J Clin Gastroenterol. 2021 Dec 6. pii: 00004836-900000000-97346.
    PubMed     Abstract available
    
    
    November 2021
58. BUFFONE E, Gupta S, Al Ibrahim B, Marshall JK, et al
    Week 2 Adalimumab Levels Predict Short-term Clinical Remission in Patients With Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2021 Nov 10. pii: 00004836-900000000-97351.
    PubMed     Abstract available
    
    
    
59. DAI C, Huang YH
    Biological Therapy in Chronic Antibiotic Refractory Pouchitis.
    J Clin Gastroenterol. 2021;55:911.
    PubMed    
    
    
    September 2021
60. MARINELLI C, Zingone F, Lupo MG, Marin R, et al
    Serum Levels of PCSK9 Are Increased in Patients With Active Ulcerative Colitis Representing a Potential Biomarker of Disease Activity: A Cross-sectional Study.
    J Clin Gastroenterol. 2021 Sep 22. pii: 00004836-900000000-97369.
    PubMed     Abstract available
    
    
    
61. JENA A, Dutta U, Shah J, Sharma V, et al
    Oral Fluconazole Therapy in Patients With Active Ulcerative Colitis Who Have Detectable Candida in the Stool: A Double-Blind Randomized Placebo-controlled Trial.
    J Clin Gastroenterol. 2021 Sep 9. pii: 00004836-900000000-97371.
    PubMed     Abstract available
    
    
    
62. TANEJA V, El-Dallal M, Haq Z, Tripathi K, et al
    Effectiveness and Safety of Tofacitinib for Ulcerative Colitis: Systematic Review and Meta-analysis.
    J Clin Gastroenterol. 2021 Sep 9. pii: 00004836-900000000-97370.
    PubMed     Abstract available
    
    
    
63. LIPCSEY M, Stein DJ, DeVore ZG, Feuerstein JD, et al
    Rising Rate of Obesity in Patients Admitted for Crohn's Disease Increases Costs But Not Mortality.
    J Clin Gastroenterol. 2021;55:716-720.
    PubMed     Abstract available
    
    
    July 2021
64. AOUN R, Jabak S, Mourad FH, Francis FF, et al
    First or Second Biologic in Inflammatory Bowel Disease: Combination Therapy or Monotherapy?
    J Clin Gastroenterol. 2021 Jul 22. pii: 00004836-900000000-97390.
    PubMed     Abstract available
    
    
    
65. HAIDER M, Lashner B
    Dual Targeted Therapy for the Management of Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2021 Jul 8. pii: 00004836-900000000-97396.
    PubMed     Abstract available
    
    
    
66. CHANDAN S, Mohan BP, Kumar A, Khan SR, et al
    Safety and Efficacy of Biological Therapy in Chronic Antibiotic Refractory Pouchitis: A Systematic Review With Meta-analysis.
    J Clin Gastroenterol. 2021;55:481-491.
    PubMed     Abstract available
    
    
    June 2021
67. BARNES EL, Hanson JS, Regueiro MD, Saha S, et al
    Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease: TARGET-IBD.
    J Clin Gastroenterol. 2021 Jun 11. pii: 00004836-900000000-97401.
    PubMed     Abstract available
    
    
    May 2021
68. ZAMSTEIN O, Glusman Bendersky A, Sheiner E, Landau D, et al
    Association Between Mode of Delivery of the Breech Fetus and Hospitalizations Due to Inflammatory Bowel Disease During Childhood.
    J Clin Gastroenterol. 2021 May 28. pii: 00004836-900000000-97416.
    PubMed     Abstract available
    
    
    
69. DOLINGER MT, Choi JJ, Phan BL, Rosenberg HK, et al
    Use of Small Bowel Ultrasound to Predict Response to Infliximab Induction in Pediatric Crohn's Disease.
    J Clin Gastroenterol. 2021;55:429-432.
    PubMed     Abstract available
    
    
    April 2021
70. KOCHAR B, Jiang Y, Long MD
    Patients With Inflammatory Bowel Diseases Are at Higher Risk for Meningitis.
    J Clin Gastroenterol. 2021;55:350-354.
    PubMed     Abstract available
    
    
    February 2021
71. SCHLABITZ F, Teich N, Riesner-Wehner A, Bohm S, et al
    Inflammatory Bowel Disease and COVID-19: How Have Patients Coped So Far?
    J Clin Gastroenterol. 2021 Feb 3. pii: 00004836-900000000-97473.
    PubMed     Abstract available
    
    
    
72. HASHASH JG, Beatty PL, Critelli K, Hartman DJ, et al
    Altered Expression of the Epithelial Mucin MUC1 Accompanies Endoscopic Recurrence of Postoperative Crohn's Disease.
    J Clin Gastroenterol. 2021;55:127-133.
    PubMed     Abstract available
    
    
    January 2021
73. BANERJEE R, Pal P, Adigopula B, Reddy DN, et al
    Impact of Demographic, Clinical and Psychosocial Variables on Drug Adherence and Outcomes in Indian Patients With Inflammatory Bowel Disease: Cost is not the Only Factor!
    J Clin Gastroenterol. 2021;Publish Ahead of Print.
    PubMed     Abstract available
    
    
    
74. MORTENSEN JH, van Haaften WT, Karsdal MA, Bay-Jensen AC, et al
    The Citrullinated and MMP-degraded Vimentin Biomarker (VICM) Predicts Early Response to Anti-TNFalpha Treatment in Crohn's Disease.
    J Clin Gastroenterol. 2021;55:59-66.
    PubMed     Abstract available
    
    
    November 2020
75. SCHWARTZ J, Stein DJ, Lipcsey M, Li B, et al
    High Rates of Mortality in Geriatric Patients Admitted for Inflammatory Bowel Disease Management.
    J Clin Gastroenterol. 2020 Nov 23. doi: 10.1097/MCG.0000000000001458.
    PubMed     Abstract available
    
    
    October 2020
76. KREDENTSER MS, Graff LA, Bernstein CN
    Psychological Comorbidity and Intervention in Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2020 Oct 27. doi: 10.1097/MCG.0000000000001463.
    PubMed     Abstract available
    
    
    
77. TUNIO NA, Mansoor E, Sheriff MZ, Cooper GS, et al
    Epidemiology of Autoimmune Hepatitis (AIH) in the United States Between 2014 and 2019: A Population-based National Study.
    J Clin Gastroenterol. 2020 Oct 16. doi: 10.1097/MCG.0000000000001449.
    PubMed     Abstract available
    
    
    
78. EL AMROUSY D, El Ashry H, Hodeib H, Hassan S, et al
    Vitamin D in Children With Inflammatory Bowel Disease: A Randomized Controlled Clinical Trial.
    J Clin Gastroenterol. 2020 Oct 14. doi: 10.1097/MCG.0000000000001443.
    PubMed     Abstract available
    
    
    
79. RITTER E, Hirsch A, Isakov NF, Ron Y, et al
    Higher Maintenance Adalimumab Trough Levels are Associated With Achievement of Advanced Remission Targets in Patients With Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2020 Oct 14. doi: 10.1097/MCG.0000000000001435.
    PubMed     Abstract available
    
    
    
80. CROOKS B, McLaughlin J, Limdi JK
    Disease-related Knowledge of People With Older-onset Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2020 Oct 5. doi: 10.1097/MCG.0000000000001441.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.